Jasper Hellweg Analyst PerformanceSecurity Analyst at ArgusJasper Hellweg is a stock analyst at Argus focused in the healthcare sector, covering 26 publicly traded companies. Over the past year, Jasper Hellweg has issued 15 stock ratings, including strong buy, buy, and hold recommendations. While full access to Jasper Hellweg's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jasper Hellweg's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings51 Last 8 YearsBuy Recommendations82.00% 41 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution50RatingsDistribution of strong buy, buy, hold, and sell ratings by Jasper Hellweg.RatingPercentageCount Strong Buy8.0%4 ratings Buy74.0%37 ratings Hold18.0%9 ratings Sell0.0%0 ratingsOut of 50 total stock ratings issued by Jasper Hellweg at Argus, the majority (74.0%) have been Buy recommendations, followed by 18.0% Hold and 8.0% Strong Buy.Best & Worst CallsBest Call000.0%HCAFeb 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ZTSSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE57.7% of companies on NYSE15 companiesNASDAQ42.3% of companies on NASDAQ11 companiesJasper Hellweg, an analyst at Argus, currently covers 26 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare24 companies92.3%Finance1 company3.8%Communication Services1 company3.8%Jasper Hellweg of Argus specializes in stock coverage within the Healthcare sector, with additional focus on Finance and Communication Services companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY9 companies34.6%PHARMACEUTICALS8 companies30.8%HEALTHCARE PROVIDERS & SERVICES3 companies11.5%LIFE SCIENCES TOOLS & SERVICES2 companies7.7%HEALTHCARE EQUIPMENT & SUPPLIES2 companies7.7%FINANCIAL SERVICES1 company3.8%INTERACTIVE MEDIA & SERVICES1 company3.8% About Jasper HellwegJasper covers the Pharmaceutical and Biotech industries in the Healthcare segment. Prior to joining Argus, he worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. Jasper began his career at Argus in the research department and has since widened his scope to include contributing to the Market Movers and Market Digest publications, the Vickers Weekly Insider Report, and Argus’ bespoke research on IPOs. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.Follow on LinkedIn Jasper Hellweg's Ratings History at Argus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGILDGilead Sciences11/12/2026Set Price Target$170.26$190.00$0.0000.00% ROIAMGNAmgen11/12/2026Boost Price Target$468.11$515.00Buy$0.0000.00% ROIFISVFiserv11/4/2026Upgrade$58.40$72.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.11/3/2026Initiated Coverage$150.19Strong-Buy$0.0000.00% ROILLYEli Lilly and Company10/30/2026Boost Price Target$1,432.68$1,550.00Buy$0.0000.00% ROIBIIBBiogen10/29/2026Upgrade$244.05$280.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/1/2026Upgrade$758.27$850.00Buy$0.0000.00% ROIVTRSViatris9/8/2026Boost Price Target$16.88$20.00Buy$0.0000.00% ROIILMNIllumina9/3/2026Boost Price Target$214.64$235.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.8/25/2026Boost Price Target$150.67$170.00Buy$0.0000.00% ROIAMGNAmgen8/19/2026Boost Price Target$429.74$460.00Buy$0.0000.00% ROIMRKMerck & Co., Inc.8/11/2026Boost Price Target$130.72$145.00Buy$0.0000.00% ROIBMYBristol Myers Squibb8/5/2026Upgrade$65.84$75.00Buy$0.0000.00% ROIZTSZoetis5/27/2026Downgrade$80.36Hold$0.0000.00% ROIAMGNAmgen2/6/2026Boost Price Target$376.19$400.00Buy$0.0000.00% ROIBAXBaxter International10/31/2025Downgrade$19.17Hold$00.0000.00% ROIZTSZoetis9/9/2025Reiterated Rating$151.26$190.00Buy$00.0000.00% ROIREGNRegeneron Pharmaceuticals6/30/2025Downgrade$521.00Hold$000.0000.00% ROIBMYBristol Myers Squibb4/25/2025Upgrade$48.45Hold$00.0000.00% ROIBIIBBiogen4/4/2025Downgrade$130.71Hold$000.0000.00% ROIBAXBaxter International2/24/2025Upgrade$34.61Buy$00.0000.00% ROIPRGOPerrigo1/14/2025Downgrade$24.33Hold$00.0000.00% ROIMRNAModerna12/18/2024Downgrade$40.76Hold$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsRaymond James FinancialMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.